Skip to main content
Clinical Trials/JPRN-UMIN000003230
JPRN-UMIN000003230
Completed
Phase 2

Alternative therapy using continuous intravenous administration of adrenomedullin for patients with inflammatory bowel disease - Continuous intravenous administration of adrenomedullin for patients with inflammatory bowel disease

First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki0 sites10 target enrollmentFebruary 22, 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
inflammatory bowel disease
Sponsor
First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2010
End Date
December 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients having one or more of following conditions 1\. malignancy 2\. pre\-carcinoma lesion(s) of the intestine 3\. recommended early operation 4\. cachexia 5\. severe liver dysfunction 6\. acute myocardial infarction, unstable angina, myocarditis and stroke within 1 month 7\. active infection 8\. pregnancy 9\. other inappropriate conditions by doctor decision

Outcomes

Primary Outcomes

Not specified

Similar Trials